Eli Lilly’s stock plunges as Mounjaro, Zepbound sales miss by wide margins
Eli Lilly’s stock heads for biggest selloff in 24 years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.
Source link
Eli Lilly’s stock heads for biggest selloff in 24 years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.
Source link